BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27447746)

  • 1. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
    Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
    Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
    Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
    Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
    Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study.
    Zheng HC; He HY; Wu JC; Li J; Zhao S; Zhao GF; Jiang HM; Yu XW; Li ZJ
    Oncotarget; 2017 Mar; 8(11):18322-18336. PubMed ID: 28407690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis.
    Zhu R; Zou ST; Wan JM; Li W; Li XL; Zhu W
    Oncol Rep; 2013 Nov; 30(5):2137-44. PubMed ID: 23982470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
    Zhao S; Yang XF; Shen DF; Gao Y; Shi S; Wu JC; Liu HX; Sun HZ; Su RJ; Zheng HC
    Oncotarget; 2016 Aug; 7(34):54596-54615. PubMed ID: 27409347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells.
    Xiong L; Liu Z; Ouyang G; Lin L; Huang H; Kang H; Chen W; Miao X; Wen Y
    Oncotarget; 2017 Jan; 8(4):6419-6432. PubMed ID: 28031534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
    Zhang T; Jiang B; Zou ST; Liu F; Hua D
    World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo.
    Yin A; Jiang Y; Zhang X; Zhao J; Luo H
    Eur J Pharmacol; 2010 Dec; 649(1-3):120-6. PubMed ID: 20869960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.
    Jagadish N; Parashar D; Gupta N; Agarwal S; Purohit S; Kumar V; Sharma A; Fatima R; Topno AP; Shaha C; Suri A
    J Exp Clin Cancer Res; 2015 Nov; 34():142. PubMed ID: 26590805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
    BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
    Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C
    J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
    Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.